Skip to main content

BioCardia, Inc. (BCDA)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.79
As of

Kresmion compiles this page from BCDA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

BioCardia, Inc. (BCDA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-12.

As of . Source: SEC EDGAR filings for BCDA. Method and limitations.

COMPANY DOSSIER

See the full BCDA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for BCDA on one page. Preview it with sample data, then open it live with a free account.

Preview the BCDA dossier

Active events for BCDA

FREE, NO ACCOUNT

Every event on BCDA, as it fires

You are seeing 5 of 7 events recorded on BCDA since 2026-06-15.

The five above landed across 4 days. The other 2 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, BCDA

Going concern statement

BCDA's 10-Q filed Nov 12, 2026 states:

These factors raise substantial doubt about our ability to continue as a going concern beyond one year from the date these financial statements are issued.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on BCDA

BCDA against its peers

BCDA's return on equity of -919.3% ranks in the 8th percentile of 19 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.

MetricBCDAPeer medianPercentilen
Revenue FY0.0 USD1.0M USD1113
Gross marginn/a64.8%n/a5
Operating marginn/a-1315.4%n/a11
Net marginn/a-1256.8%n/a11
Return on equity-919.3%-151.2%819
1 year-40.1%-61.2%6618

Peers (23): PASG, TVRD, TCRX, AEON, DARE, ADIL, SYBX, CLGN, DYAI, INTI, GUTS, CLRB, HEPA, BIVI, ASBP, CKDXF, PBM, ANEB, PTN, MRKR, BOLT, LSTA, HIND. Left out: QNTM (no annual filing), HOOK.D (period gap). Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BCDA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Cite this data

Kresmion counts the managers it follows that reported a non-option position in BCDA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BCDA in the last 180 days.

Upstream: SEC EDGAR filings for BCDA

Kresmion, "BioCardia, Inc. (BCDA) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/BCDA. Upstream data: SEC EDGAR filings for BCDA.

Link to this data (HTML):

<a href="https://kresmion.com/research/BCDA">BioCardia, Inc. (BCDA) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow BCDA on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BCDA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the BCDA dossier
Share

The BCDA intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.